AyushNet
Nutraceutical strategies for the management of menopausal complaints
Article

Nutraceutical strategies for the management of menopausal complaints

Introduction

Menopause is a natural biological transition characterized by the cessation of ovarian function and declining estrogen levels, often accompanied by vasomotor symptoms, sleep disturbances, mood changes, urogenital atrophy, and metabolic alterations. Although hormone replacement therapy (HRT) remains the most effective treatment for moderate to severe menopausal symptoms, its use is sometimes limited by contraindications and safety concerns. Consequently, there is increasing interest in nutraceutical and plant-based interventions as alternative or adjunctive options for symptom relief. A wide range of herbal nutraceuticals have been investigated for their phytoestrogenic, neuroendocrine, anti-inflammatory, and antioxidant properties, offering potential benefits in the management of menopausal complaints.

Phytoestrogenic and hormone-modulating herbs

Several nutraceuticals exert estrogen-like activity and modulate hormonal balance.

  • Actaea racemosa (black cohosh) is among the most extensively studied herbs for menopausal symptoms, particularly hot flashes and sleep disturbances. Its terpene glycosides interact with estrogen receptors and modulate luteinizing hormone secretion, though concerns regarding gastrointestinal side effects and potential hepatotoxicity persist.
  • Glycyrrhiza glabra (licorice) contains flavonoids and isoflavonoids with estrogenic properties and has demonstrated efficacy in reducing hot flash duration, although prolonged use may lead to metabolic disturbances such as hypokalemia and hypertension.
  • Similarly, Trifolium pratense (red clover), rich in isoflavones, has shown benefits in reducing vasomotor symptom frequency and severity while potentially supporting bone health, though long-term safety data remain limited.
  • Vitex agnus-castus (chasteberry) influences melatonin and opioid pathways and may improve sleep quality, vasomotor symptoms, and mood fluctuations, while also addressing premenstrual and reproductive complaints.

Neuropsychological and sedative nutraceuticals

Menopausal symptoms frequently include anxiety, insomnia, and mood disturbances.

  • Melissa officinalis (lemon balm) exhibits anxiolytic, antispasmodic, and neurocognitive effects mediated through flavonoids and phenolic compounds, supporting emotional well-being without significant reported adverse effects.
  • Passiflora incarnata (passionflower) is traditionally used for insomnia and anxiety and has demonstrated sedative and analgesic properties, making it useful in early menopausal neurovegetative symptoms.
  • Likewise, Valeriana officinalis (valerian) enhances GABAergic activity, promoting sleep quality and reducing anxiety, while also showing potential in alleviating hot flashes.
  • Hypericum perforatum (St. John’s wort) has demonstrated antidepressant effects through modulation of neurotransmitter pathways and may improve vasomotor symptoms and mood disorders. However, it carries risks of gastrointestinal discomfort, photosensitivity, and drug interactions.

Vasomotor symptom-targeted botanicals

Hot flashes remain one of the most distressing menopausal symptoms.

  • Foeniculum vulgare (fennel) exhibits mild estrogenic and anti-inflammatory activity and has been shown to reduce hot flashes and improve vaginal atrophy and sexual function.
  • Pimpinella anisum (anise) also demonstrates estrogen-like effects and is traditionally used for vasomotor symptom relief with an additional gastrointestinal calming effect.
  • Salvia officinalis (sage) modulates neurotransmitter pathways, including GABA and serotonin systems, and has been associated with reduced sweating and hot flash severity, although excessive intake may cause neurological side effects.
  • Panax ginseng, rich in ginsenosides, shows potential in improving mood, sexual function, and metabolic regulation, though its effect on vasomotor symptoms requires further validation.

Metabolic, anti-inflammatory, and bone health support

Menopause is associated with increased risk of metabolic syndrome and osteoporosis.

  • Medicago sativa (alfalfa) contains bioactive polysaccharides with immunomodulatory and antioxidant properties and may support neurovegetative symptom relief, although safety concerns such as microbial contamination have been reported.
  • Trigonella foenum-graecum (fenugreek) demonstrates potential benefits in glucose regulation and prevention of menopausal osteopenia. Similarly, licorice and red clover contribute to estrogenic and bone-protective effects.

Safety considerations and emerging evidence

  • While many nutraceuticals demonstrate promising therapeutic effects, safety profiles vary significantly.
  • Some herbs, such as black cohosh and sage, have been associated with gastrointestinal or neurological adverse effects, while others require caution due to endocrine or cardiovascular interactions. Importantly, long-term safety data remain limited for several agents, emphasizing the need for standardized dosing, quality control, and rigorous clinical evaluation.

Conclusion

Nutraceutical interventions represent a promising complementary strategy for managing menopausal complaints, targeting vasomotor, psychological, urogenital, and metabolic symptoms through diverse bioactive mechanisms. Herbs such as black cohosh, red clover, fennel, valerian, passionflower, and sage demonstrate varying degrees of efficacy in symptom relief, particularly for hot flashes, sleep disturbances, and mood disorders. However, despite encouraging clinical evidence, variability in study design and safety concerns necessitate further high-quality randomized controlled trials. Integrating nutraceuticals into menopausal care should therefore be approached cautiously, ensuring evidence-based use, individualized treatment selection, and ongoing safety monitoring to optimize patient outcomes.1

References:

De Franciscis P, Colacurci N, Riemma G, et al. A Nutraceutical Approach to Menopausal Complaints. Medicina (Kaunas). 2019;55(9):544. Published 2019 Aug 28. doi:10.3390/medicina55090544 https://pmc.ncbi.nlm.nih.gov/articles/PMC6780855/#sec4-medicina-55-00544